parathyroid hormone
AssetPeptideAlso Parathyroid hormone (PTH), ZP-PTH
PTH receptor agonist delivered transdermally to stimulate bone formation
- Stage
- Phase 3
- Modality
- Peptide
- Target
- PTH1R
- Indications
- 3
- Trials
- 9
- Developers
- 3
Indications
3Osteoporosis
Phase 3COMPLETEDNCT00365456clinicaltrials.gov7 Oct 2026
Postmenopausal women with primary osteoporosis
Phase 3COMPLETEDNCT00583518clinicaltrials.gov7 Oct 2026
Postmenopausal osteoporosis
Phase 1COMPLETEDNCT02478879clinicaltrials.gov7 Oct 2026
- Targets and what it contains1
- Owner and partners3
- Trials9
- Evidence for its targets1
- Competitors3
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 6 sources